The red warning flag is waving for these 3 pot stocks

Although it’s still very early in the legalization process, marijuana offers the potential of being a once-in-a-lifetime growth opportunity. After racking up only $5.4 billion in global legal sales in 2015, Cowen Group analyst Vivien Azer foresees $75 billion in…

Surprise! Warren Buffett’s Portfolio Has Marijuana Exposure

Just a few weeks ago, the Oracle of Omaha, Warren Buffett, wrapped up another highly successful annual shareholder meeting for the conglomerate he’s run for decades, Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B). This event has become something of a mecca for investing enthusiasts, allowing them to listen…

How Did Tilray Stack Up to the Competition?

Tilray

In the market for licensed Cannabis, Tilray (NASDAQ:TLRY) only has three larger competitors. Aurora Cannabis (NYSE:ACB), is much larger than Tilray, and Cronos Group (NASDAQ:CRON) is nearly the same size. Canopy Growth‘s $15.4 billion market cap is more than three times Tilray’s size, and since Canopy hasn’t reported yet,…

The 3 Best Marijuana Stocks to Buy Right Now

Marijuana Stocks

Since their inception, marijuana stocks attracted significant attention. Due to both investment sentiment – and let’s face it, raw emotions – the cannabis sector absolutely skyrocketed. But now, the segment is attracting attention for failing to live up to analysts’…

Aurora Cannabis: 8 Facts About Its Latest Quarter

Canada’s recreational marijuana market is valued at over $5 billion Canadian ($3.71 billion) per year, and that means that leading marijuana stocks are poised to see sales skyrocket following legalization last October. To make sure it gets its fair share…